Two Sigma Securities’s Ocular Therapeutix OCUL Stock Holding History

Two Sigma Securities’s Portfolio OCUL Stock Details OCUL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-16,563	Closed	-$140K	–	2174
2026 Q1	$140K	Buy	+16,563	New	+$158K	0.02%	1118
2025 Q4	–	Sell	-17,088	Closed	-$200K	–	1858
2025 Q3	$200K	Sell	17,088 -6,143	-26%	-$73.5K	0.03%	820
2025 Q2	$216K	Buy	+23,231	New	+$182K	0.03%	878
2018 Q1	–	Sell	-10,970	Closed	-$49K	–	2871
2017 Q4	$49K	Buy	+10,970	New	+$56K	﹤0.01%	1531

Other funds holding OCUL

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return

VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Two Sigma Securities's OCUL Position: Q2 2026 in Review

Two Sigma Securities sold out of Ocular Therapeutix (OCUL) in Q2 2026, closing a stake of 16,563 shares — an estimated $140K sold.

Two Sigma Securities first reported a position in OCUL in Q4 2017 and held it in 4 quarters. The position peaked at $216K in Q2 2025. 262 funds tracked by Wall St. Rank hold OCUL as of Q2 2026.

Two Sigma Securities reported no remaining Ocular Therapeutix position as of Q2 2026 after selling out during the quarter.
Two Sigma Securities sold 16,563 Ocular Therapeutix shares in Q2 2026, an estimated $140K.
Two Sigma Securities first reported a position in Ocular Therapeutix in Q4 2017 and held it in 4 quarters.
Two Sigma Securities's Ocular Therapeutix position peaked at $216K in Q2 2025.
262 funds tracked by Wall St. Rank held Ocular Therapeutix as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.